» Articles » PMID: 36080336

Chronic Treatment with Melatonin Improves Hippocampal Neurogenesis in the Aged Brain and Under Neurodegeneration

Abstract

Adult hippocampal neurogenesis is altered during aging and under different neuropsychiatric and neurodegenerative diseases. Melatonin shows neurogenic and neuroprotective properties during aging and neuropathological conditions. In this study, we evaluated the effects of chronic treatment with melatonin on different markers of neurodegeneration and hippocampal neurogenesis using immunohistochemistry in the aged and neurodegenerative brains of SAMP8 mice, which is an animal model of accelerated senescence that mimics aging-related Alzheimer's pathology. Neurodegenerative processes observed in the brains of aged SAMP8 mice at 10 months of age include the presence of damaged neurons, disorganization in the layers of the brain cortex, alterations in neural processes and the length of neuronal prolongations and β-amyloid accumulation in the cortex and hippocampus. This neurodegeneration may be associated with neurogenic responses in the hippocampal dentate gyrus of these mice, since we observed a neurogenic niche of neural stem and progenitor/precursors cells in the hippocampus of SAMP8 mice. However, hippocampal neurogenesis seems to be compromised due to alterations in the cell survival, migration and/or neuronal maturation of neural precursor cells due to the neurodegeneration levels in these mice. Chronic treatment with melatonin for 9 months decreased these neurodegenerative processes and the neurodegeneration-induced neurogenic response. Noticeably, melatonin also induced recovery in the functionality of adult hippocampal neurogenesis in aged SAMP8 mice.

Citing Articles

Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration.

Yehia A, Abulseoud O Mol Neurodegener. 2024; 19(1):36.

PMID: 38641847 PMC: 11031980. DOI: 10.1186/s13024-024-00728-6.


Melatonin Modulates Cell Cycle Dynamics and Promotes Hippocampal Cell Proliferation After Ischemic Injury in Neonatal Rats.

Canonico B, Carloni S, Montanari M, Ambrogini P, Papa S, Alonso-Alconada D Mol Neurobiol. 2024; 61(9):6910-6919.

PMID: 38358438 PMC: 11339182. DOI: 10.1007/s12035-024-04013-x.


Special Issue on "Pleiotropic Benefits of Melatonin: From Basic Mechanisms to Disease".

Potes Y, Caballero B Int J Mol Sci. 2023; 24(6).

PMID: 36982298 PMC: 10048954. DOI: 10.3390/ijms24065223.


Benefits of the Neurogenic Potential of Melatonin for Treating Neurological and Neuropsychiatric Disorders.

Potes Y, Cachan-Vega C, Antuna E, Garcia-Gonzalez C, Menendez-Coto N, Boga J Int J Mol Sci. 2023; 24(5).

PMID: 36902233 PMC: 10002978. DOI: 10.3390/ijms24054803.

References
1.
Cheng S, Ma C, Qu H, Fan W, Pang J, He H . Differential effects of melatonin on hippocampal neurodegeneration in different aged accelerated senescence prone mouse-8. Neuro Endocrinol Lett. 2008; 29(1):91-9. View

2.
Sarlak G, Jenwitheesuk A, Chetsawang B, Govitrapong P . Effects of melatonin on nervous system aging: neurogenesis and neurodegeneration. J Pharmacol Sci. 2013; 123(1):9-24. DOI: 10.1254/jphs.13r01sr. View

3.
Rennie K, De Butte M, Pappas B . Melatonin promotes neurogenesis in dentate gyrus in the pinealectomized rat. J Pineal Res. 2009; 47(4):313-7. DOI: 10.1111/j.1600-079X.2009.00716.x. View

4.
Hodge R, Kowalczyk T, Wolf S, Encinas J, Rippey C, Enikolopov G . Intermediate progenitors in adult hippocampal neurogenesis: Tbr2 expression and coordinate regulation of neuronal output. J Neurosci. 2008; 28(14):3707-17. PMC: 6671086. DOI: 10.1523/JNEUROSCI.4280-07.2008. View

5.
Diaz-Moreno M, Armenteros T, Gradari S, Hortiguela R, Garcia-Corzo L, Fontan-Lozano A . Noggin rescues age-related stem cell loss in the brain of senescent mice with neurodegenerative pathology. Proc Natl Acad Sci U S A. 2018; 115(45):11625-11630. PMC: 6233090. DOI: 10.1073/pnas.1813205115. View